Retina/Vitreous

Top Story

Enrollment complete in Zimura trial for geographic atrophy

October 11, 2018

Nightstar’s gene therapy for X-linked retinitis pigmentosa shows positive early results

October 10, 2018
NSR-RPGR, a gene therapy treatment for X-linked retinitis pigmentosa, showed positive preliminary results in a phase 1/2 dose-escalation study, Nightstar Therapeutics…

Sustained delivery system intended to ease AMD treatment burden

Ocular Surgery News U.S. Edition, October 10, 2018
A new port delivery system may secure sustained, long-term release of anti-VEGF in patients with wet age-related macular degeneration, easing the burden of repeated…

Letter to the Editor

Ocular Surgery News U.S. Edition, October 10, 2018
To the editor: I am writing in response to the June 25, 2018, commentary regarding the evolution of care models for diabetic macular edema. I think the conclusions…
More Headlines »
Clinical Science Imaging

Enhanced Depth Imaging Optical Coherence Tomography: Choroidal Thickness and Correlations With Age, Refractive Error, and Axial Length

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
To evaluate choroidal thickness at five macular locations and assess the correlations between choroidal thickness at…
More »
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because…
More »
Resource Centers
Video From OSN Europe
Meeting News

VIDEO: OCT measures cytokine changes in DME treatments

September 29, 2018
More »

Enrollment complete in Zimura trial for geographic atrophy

October 11, 2018
Patient recruitment is complete for a phase 2b clinical trial of Zimura monotherapy for geographic atrophy secondary to dry age-related macular…

Nightstar’s gene therapy for X-linked retinitis pigmentosa shows positive early results

October 10, 2018
NSR-RPGR, a gene therapy treatment for X-linked retinitis pigmentosa, showed positive preliminary results in a phase 1/2 dose-escalation study…

Sustained delivery system intended to ease AMD treatment burden

Ocular Surgery News U.S. Edition, October 10, 2018
A new port delivery system may secure sustained, long-term release of anti-VEGF in patients with wet age-related macular degeneration, easing the…

Letter to the Editor

Ocular Surgery News U.S. Edition, October 10, 2018
To the editor: I am writing in response to the June 25, 2018, commentary regarding the evolution of care models for diabetic macular edema. I think…

Brolucizumab meets secondary endpoints for fluid resolution in wet AMD

October 9, 2018
A new data analysis of prespecified secondary endpoints of the phase 3 HAWK and HARRIER trials showed that retinal fluid was detected less often in…

Regenxbio completes dosing in phase 1 trial of gene therapy for wet AMD

October 8, 2018
Dosing is complete in a phase 1 clinical trial of RGX-314, a gene therapy treatment for wet age-related macular degeneration, according to a press…

Meeting NewsVideoFrom OSN Europe

VIDEO: Large cohort shows safety of Ozurdex for DME

October 8, 2018
VIENNA At the Euretina meeting here, Jay Chhablani, MD, discusses safety results of a large cohort of patients with diabetic macular edema treated…

Meeting NewsVideoFrom OSN Europe

VIDEO: Biologics have changed approach to treatment of uveitis

October 6, 2018
VIENNA — At the Euretina meeting, Marc de Smet, MD, PhD, speaks about the use of biologics in uveitis and gives pearls on indications

Meeting NewsVideoFrom OSN Europe

VIDEO: Topical treatment of AMD shows promise in early stages of clinical trial

October 5, 2018
VIENNA — At the Euretina meeting, Hemal Mehta, MD, speaks about the early results of the PanOptica clinical trial on a new molecule for the

Meeting NewsFrom OSN Europe

Specialist shares key messages of Euretina guidelines for management of RVO

October 4, 2018
VIENNA — A thorough ocular examination, early treatment and a timely switch of nonresponders are key for successful management of retinal vein…

Meeting NewsFrom OSN Europe

3-D system offers advantages for learning surgery

October 3, 2018
VIENNA — There is no reason to be afraid of using a heads-up 3-D viewing modality to perform surgery because the advantages are immediately…

VideoFrom OSN Europe

VIDEO: DME non-responders to anti-VEGF may benefit from dexamethasone implant

October 2, 2018
VIENNA — At the Euretina meeting, Catharina Busch, MD, discusses the results of a study showing patients with diabetic macular edema who do not…

From OSN Europe

MacuLogix launches AdaptDx for early AMD detection

October 2, 2018
MacuLogix Inc. has launched AdaptDx in Europe at the Euretina meeting in Vienna. The dark adaptometer is designed for clinical use to detect…

Meeting NewsFrom OSN Europe

Macula add-on lens improves quality of life for patients with AMD

October 2, 2018
VIENNA — A study assessing the quality of life of patients with age-related macular degeneration implanted with the Scharioth Macula Lens…

FDA News

FDA awards $18 million to fund trials of medical products for rare diseases

September 29, 2018
The FDA awarded more than $18 million in grants over the next 4 years to fund clinical trials of medical products intended to treat patients with…

Meeting NewsVideoFrom OSN Europe

VIDEO: OCT measures cytokine changes in DME treatments

September 29, 2018
VIENNA ― Javier Zarranz-Ventura, MD, PhD, discusses his presentation at the Euretina meeting in which he reviewed the use of OCT to observe cytokine…

Meeting NewsFrom OSN Europe

Prolonged aflibercept dosing intervals yield consistent results for treating AMD

September 28, 2018
VIENNA — Ninety-six-week outcomes of the ALTAIR study demonstrated safety and efficacy of treat-and-extend aflibercept administration with both…

Meeting NewsFrom OSN Europe

Corticosteroid implant shows positive real-world outcomes in severe cases of DME

September 28, 2018
VIENNA — Real-world 3-year data from the RETRO-IDEAL study showed that advanced diabetic macular edema cases can benefit from being treated…

Meeting NewsVideoFrom OSN Europe

VIDEO: New advances in retina highlighted

September 28, 2018
VIENNA — At the Euretina meeting, José García-Arumi, MD, PhD, gives highlights on the latest advancements in retina, including

Meeting NewsFrom OSN Europe

Endophthalmitis rate remains low after repeat injections

September 26, 2018
VIENNA — A study conducted on a large database showed that the rate of endophthalmitis following intravitreal injections is low and does not…

More Headlines »
Healio Jobs